350 related articles for article (PubMed ID: 16515655)
1. Ciprofloxacin as a representative of disk diffusion in vitro susceptibility of enrofloxacin for bacterial organisms from the middle-ear tissue of dogs with end-stage otitis externa.
Cole LK; Kwochka KW; Hillier A; Kowalski JJ; Smeak DD; Kelbick NT
Vet Dermatol; 2006 Apr; 17(2):128-33. PubMed ID: 16515655
[TBL] [Abstract][Full Text] [Related]
2. Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin.
Cole LK; Papich MG; Kwochka KW; Hillier A; Smeak DD; Lehman AM
Vet Dermatol; 2009 Feb; 20(1):51-9. PubMed ID: 19152587
[TBL] [Abstract][Full Text] [Related]
3. Comparison of bacterial organisms and their susceptibility patterns from otic exudate and ear tissue from the vertical ear canal of dogs undergoing a total ear canal ablation.
Cole LK; Kwochka KW; Hillier A; Kowalski JJ; Smeak DD
Vet Ther; 2005; 6(3):252-9. PubMed ID: 16299671
[TBL] [Abstract][Full Text] [Related]
4. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
Brothers AM; Gibbs PS; Wooley RE
Vet Ther; 2002; 3(4):493-500. PubMed ID: 12584687
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa.
Rougier S; Borell D; Pheulpin S; Woehrlé F; Boisramé B
Vet Dermatol; 2005 Oct; 16(5):299-307. PubMed ID: 16238809
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin.
Wildermuth BE; Griffin CE; Rosenkrantz WS; Boord MJ
J Am Anim Hosp Assoc; 2007; 43(6):337-41. PubMed ID: 17975216
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.
Gottlieb S; Wigney DI; Martin PA; Norris JM; Malik R; Govendir M
Aust Vet J; 2008 Apr; 86(4):147-52. PubMed ID: 18363989
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.
Boothe DM; Boeckh A; Simpson RB; Dubose K
J Vet Intern Med; 2006; 20(6):1297-306. PubMed ID: 17186841
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
[TBL] [Abstract][Full Text] [Related]
10. Variability of laboratory identification and antibiotic susceptibility reporting of Pseudomonas spp. isolates from dogs with chronic otitis externa.
Schick AE; Angus JC; Coyner KS
Vet Dermatol; 2007 Apr; 18(2):120-6. PubMed ID: 17355427
[TBL] [Abstract][Full Text] [Related]
11. Wound contamination and antimicrobial susceptibility of bacteria cultured during total ear canal ablation and lateral bulla osteotomy in dogs.
Vogel PL; Komtebedde J; Hirsh DC; Kass PH
J Am Vet Med Assoc; 1999 Jun; 214(11):1641-3. PubMed ID: 10363095
[TBL] [Abstract][Full Text] [Related]
12. Identification and antimicrobial susceptibility of bacteria and yeasts isolated from healthy dogs and dogs with otitis externa.
Lyskova P; Vydrzalova M; Mazurova J
J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):559-63. PubMed ID: 18045339
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of an ear rinse containing tromethamine, EDTA, benzyl alcohol and 0.1% ketoconazole on Malassezia organisms from dogs with otitis externa.
Cole LK; Luu DH; Rajala-Schultz PJ; Meadows C; Torres AH
Vet Dermatol; 2007 Apr; 18(2):115-9. PubMed ID: 17355426
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of Fluoroquinolone- and Methicillin-resistant Staphylococcus pseudintermedius isolates from canine pyoderma and otitis externa in veterinary teaching hospital.
Yoo JH; Yoon JW; Lee SY; Park HM
J Microbiol Biotechnol; 2010 Apr; 20(4):798-802. PubMed ID: 20467256
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates from dogs with otitis externa.
Mekić S; Matanović K; Šeol B
Vet Rec; 2011 Jul; 169(5):125. PubMed ID: 21742683
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an ear cleanser for the treatment of infectious otitis externa in dogs.
Cole LK; Kwochka KW; Kowalski JJ; Hillier A; Hoshaw-Woodard SL
Vet Ther; 2003; 4(1):12-23. PubMed ID: 12756632
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of an antiseptic and microbial anti-adhesive ear cleanser in dogs with otitis externa.
Rème CA; Pin D; Collinot C; Cadiergues MC; Joyce JA; Fontaine J
Vet Ther; 2006; 7(1):15-26. PubMed ID: 16598680
[TBL] [Abstract][Full Text] [Related]
18. [Microbiological results of ear swabs from dogs and cats].
Müller E; Heusinger A
Tierarztl Prax; 1994 Feb; 22(1):80-4. PubMed ID: 8165666
[TBL] [Abstract][Full Text] [Related]
19. Identification and antimicrobial susceptibility patterns of bacteria causing otitis externa in dogs.
Zamankhan Malayeri H; Jamshidi S; Zahraei Salehi T
Vet Res Commun; 2010 Jun; 34(5):435-44. PubMed ID: 20526674
[TBL] [Abstract][Full Text] [Related]
20. Otitis externa infection in Jordan. Clinical and microbiological features.
Battikhi MN; Ammar SI
Saudi Med J; 2004 Sep; 25(9):1199-203. PubMed ID: 15448765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
